Clinical Trial Update: A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ⅰb/Ⅱ clinical trial evaluating clifutinib besylate in combination with chemotherapy for newly diagnosed acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clifutinib Besylate (clifutinib besylate)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Acute Myeloid Leukemia, Adult | Phase 1, Phase 2 | Status: RECRUITING